BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1447 related articles for article (PubMed ID: 15751097)

  • 1. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
    Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
    Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.
    Gabriel SE; Crowson CS; Kremers HM; Doran MF; Turesson C; O'Fallon WM; Matteson EL
    Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity in arthritis.
    Gabriel SE; Crowson CS; O'Fallon WM
    J Rheumatol; 1999 Nov; 26(11):2475-9. PubMed ID: 10555912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of infection in rheumatoid arthritis.
    Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
    Arthritis Rheum; 2002 Sep; 46(9):2294-300. PubMed ID: 12355476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
    Crowson CS; Nicola PJ; Kremers HM; O'Fallon WM; Therneau TM; Jacobsen SJ; Roger VL; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Oct; 52(10):3039-44. PubMed ID: 16200583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
    Nicola PJ; Crowson CS; Maradit-Kremers H; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2006 Jan; 54(1):60-7. PubMed ID: 16385496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The widening mortality gap between rheumatoid arthritis patients and the general population.
    Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.
    Escalante A; Haas RW; del Rincón I
    Arch Intern Med; 2005 Jul; 165(14):1624-9. PubMed ID: 16043681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
    Kapetanovic MC; Lindqvist E; Simonsson M; Geborek P; Saxne T; Eberhardt K
    Scand J Rheumatol; 2010; 39(5):353-9. PubMed ID: 20615160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
    Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
    Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
    J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
    Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
    Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.